Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry
Temsavir, a compound that inhibits HIV entry by binding envelope (Env), is currently in clinical development. Here, Lai et al. identify a more than 10-fold improved compound and, using lattice engineering, obtain crystal structures that give insights into improved inhibition between small molecules...
Guardado en:
Autores principales: | Yen-Ting Lai, Tao Wang, Sijy O’Dell, Mark K. Louder, Arne Schön, Crystal S. F. Cheung, Gwo-Yu Chuang, Aliaksandr Druz, Bob Lin, Krisha McKee, Dongjun Peng, Yongping Yang, Baoshan Zhang, Alon Herschhorn, Joseph Sodroski, Robert T. Bailer, Nicole A. Doria-Rose, John R. Mascola, David R. Langley, Peter D. Kwong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8c1780f80cef41df909afde553e1a2ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity
por: James J. Steinhardt, et al.
Publicado: (2018) -
Rhesus Macaque B-Cell Responses to an HIV-1 Trimer Vaccine Revealed by Unbiased Longitudinal Repertoire Analysis
por: Kaifan Dai, et al.
Publicado: (2015) -
The β20–β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions
por: Alon Herschhorn, et al.
Publicado: (2017) -
Publisher Correction: The β20–β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions
por: Alon Herschhorn, et al.
Publicado: (2018) -
Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces
por: Myungjin Lee, et al.
Publicado: (2021)